Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,008
Closed -$566K 725
2025
Q4
$566K Sell
1,008
-9
-0.9% -$5.11K 0.02% 438
2025
Q3
$523K Sell
1,017
-27
-3% -$11.8K 0.02% 454
2025
Q2
$328K Sell
1,044
-47
-4% -$14.1K 0.01% 541
2025
Q1
$332K Hold
1,091
0.01% 534
2024
Q4
$362K Hold
1,091
0.01% 500
2024
Q3
$364K Sell
1,091
-100
-8% -$38K 0.02% 496
2024
Q2
$491K Buy
1,191
+18
+2% +$7.13K 0.02% 415
2024
Q1
$474K Sell
1,173
-327
-22% -$115K 0.02% 420
2023
Q4
$460K Hold
1,500
0.02% 418
2023
Q3
$363K Sell
1,500
-921
-38% -$236K 0.02% 448
2023
Q2
$581K Buy
+2,421
New +$503K 0.03% 371

Other funds holding MEDP

Argent Trust Co's MEDP Position: Q1 2026 in Review

Argent Trust Co sold out of Medpace (MEDP) in Q1 2026, closing a stake of 1,008 shares — an estimated $566K sold.

Argent Trust Co first reported a position in MEDP in Q2 2023 and held it in 11 quarters. The position peaked at $581K in Q2 2023. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Argent Trust Co reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Argent Trust Co sold 1,008 Medpace shares in Q1 2026, an estimated $566K.
  • Argent Trust Co first reported a position in Medpace in Q2 2023 and held it in 11 quarters.
  • Argent Trust Co's Medpace position peaked at $581K in Q2 2023.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.